Mecovixr NP Tablet is a combination medication containing Pregabalin 75mg, Nortriptyline 10mg, and Methylcobalamin 1500mcg, formulated to provide effective management of neuropathic pain and associated neurological conditions. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, modulates calcium channels in the central nervous system, thereby reducing neuronal excitability and alleviating neuropathic pain symptoms. Nortriptyline, a tricyclic antidepressant, enhances noradrenaline and serotonin levels by inhibiting their reuptake, contributing to analgesic effects and mood stabilization in patients with chronic pain. Methylcobalamin, an active form of vitamin B12, supports nerve regeneration and repair by facilitating myelin sheath synthesis and promoting neuronal health. The synergistic action of these components makes Mecovixr NP Tablet suitable for the treatment of diabetic neuropathy, postherpetic neuralgia, and other peripheral neuropathies. It is recommended to be administered under medical supervision, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include dizziness, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with renal impairment, cardiovascular disorders, and those on concomitant CNS depressants. Mecovixr NP Tablet offers a comprehensive therapeutic approach targeting both symptomatic relief and underlying nerve repair mechanisms.